image
ABVC BioPharma, Inc. ABVC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.5
-9.26 %
$ 6.21 M
Market Cap
-0.3
P/E
CASH FLOW STATEMENT
-4.24 M OPERATING CASH FLOW
42.75%
Growth Rates
1Year 42.75%
3Years 2.46%
5Years -46.38%
7Years -2.87%
10Years -60.32%
-360 K INVESTING CASH FLOW
79.08%
Growth Rates
1Year 79.08%
3Years -16.91%
5Years -18.16%
7Years 0.00%
10Years 0.00%
3.92 M FINANCING CASH FLOW
-2.37%
Growth Rates
1Year -2.37%
3Years -25.73%
5Years 45.89%
7Years 5.73%
10Years 65.78%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis ABVC BioPharma, Inc.
image
Net Income -10.5 M
Depreciation & Amortization 28.5 K
Capital Expenditures -21.2 K
Stock-Based Compensation 1.64 M
Change in Working Capital 977 K
Others 4.27 M
Free Cash Flow -4.26 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Sep-2016 Sep-2015 Sep-2014 Sep-2013 Sep-2012 Dec-2011 Sep-2010 Sep-2009 Sep-2008 Sep-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002
OPERATING CASH FLOW
Net Income (10.5) (16.3) (12.0) (10.6) (3.9) (4.1) (6.7) (4.5) 32.3 K 70 (0.2) (1.1) (1.2) (1.9) (5.2) (6.8) (4.7) 25.4 K 16.4 K 2.54 K 25.4 K 20 K
Depreciation & Amortization 28.5 K 23.8 K 12 K 37.1 K 55.1 K 43.6 K 44 K 0 0 0 23.9 K 33 K 34.2 K 45.2 K 45.1 K 37.5 K 12.8 K 0 0 0 0 0
Deferred Income Tax 0.1 0.9 0.8 (0.2) 80.7 K (0.4) (0.4) 0 0 0 0 0 1.2 0 0 0 0 0 0 0 0 0
Stock Based Compensation 1.6 7.0 5.3 4.1 22.3 K 28.8 K 0.2 1.3 30 K 0 0 0.2 0.7 0 0 0 0 0 0 0 0 0
Other Operating Activities 3.5 0.4 91.1 K 2.2 0.2 2.5 4.3 (5.2) 23 K 0 0 (0.2) (2.0) 0.7 3.5 3.3 2.0 0 1.32 K 0 15.2 K 50 K
Change in Working Capital 1.0 0.6 (1.6) 86.4 K 0.6 0.9 0.8 (0.3) 5.64 K 1.24 K 0.2 0.1 (0.4) 0.1 77.8 K 1.1 14.7 K 49.9 K 742 9.98 K 40.9 K 40 K
Cash From Operations (4.2) (7.4) (7.6) (4.6) (3.1) (0.6) (1.7) (3.5) 3.36 K 1.17 K 37.8 K (0.9) (1.6) (1.0) (1.6) (2.3) (2.7) 24.5 K 18.4 K 7.45 K 355 10 K
INVESTING CASH FLOW
Capital Expenditures 21.2 K (0.1) 17.5 K 0 0 0 0 0 0 0 0 19.5 K 41.7 K 11.4 K 59.4 K (0.2) 97.6 K 0 0 0 0 0
Other Items (0.3) (1.6) (0.8) (0.2) 35.3 K (0.2) (7.5) 0 0 0 0 0 3 K 0 0 0 0 0 0 0 0 0
Cash From Investing Activities (0.4) (1.7) (0.8) (0.2) 35.3 K (0.2) (7.5) 0 0 0 0 19.5 K 38.7 K 11.4 K 59.4 K (0.2) 97.6 K 0 0 0 0 0
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 30 K
Total Debt Repaid 0.5 0.3 (0.2) 2.0 2.0 0.6 3.6 0 0 0 25 K 0.2 55.9 K 0.6 (0.3) 0.7 0.4 0 0 4.54 K 12 K 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 2.4 0 (0.9) 0 0.6 0 (2.0) 0.3 0 0 0 1.3 1.6 0.5 0.9 0 0 0 0 10.9 K 10.9 K 10 K
Cash From Financing Activities 3.9 4.0 10.0 9.6 3.1 0.6 9.3 2.7 1.0 1.79 K 25 K 0.9 1.7 1.1 0.6 2.7 2.9 0 0 15.5 K 0.1 10 K
CHANGE IN CASH
Net Change In Cash (0.7) (5.2) 1.6 4.8 82.3 K 37.2 K 0.2 (0.8) 1.0 618 12.8 K 58.4 K 69 K 2.81 K (1.0) 0.2 71.8 K 24.5 K 18.4 K 22.9 K 0.1 0
FREE CASH FLOW
Free Cash Flow (4.3) (7.5) (7.6) (4.6) (3.1) (0.6) (1.7) (3.5) 3.36 K 1.17 K 37.8 K (0.9) (1.6) (1.1) (1.6) (2.6) (2.8) 24.5 K 18.4 K 7.45 K 355 10 K